Related Experiment Video

Updated: Jul 3, 2026

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
12:40

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

[Virus inactivation in a single unit of plasma for transfusion]

E B Zhiburt

    Meditsinskaia Tekhnika
    |August 9, 2008
    PubMed

    Insights

    Methylene blue treatment is a practical method for inactivating viruses in plasma transfusions, significantly reducing transfusion-transmitted viral infections. This technology shows excellent viral inactivation and positive clinical outcomes in Russia.

    Area of Science:

    • Virology
    • Blood Transfusion Safety
    • Public Health

    Context:

    • Transfusion-transmitted viral infections pose a significant public health risk in Russia, primarily linked to plasma transfusions.
    • Existing viral inactivation methods may have limitations in practicality or efficacy.

    Purpose:

    • To evaluate the effectiveness and practicality of methylene blue (Macotronic) treatment for viral inactivation in plasma units.
    • To assess the clinical outcomes and social satisfaction associated with this method.

    Summary:

    • Methylene blue treatment demonstrates maximal inactivation of both enveloped and non-enveloped viruses in plasma.
    • The technology is suitable for single plasma unit inactivation, adaptable to various healthcare settings.
    • Initial implementation in Russia yielded favorable clinical results and high social satisfaction.

    Impact:

    • Methylene blue treatment offers a practical and effective solution to mitigate transfusion-transmitted viral infections.
    • This approach enhances the safety of plasma transfusions, potentially improving patient outcomes and public health.
    • The decentralized application of this technology can broaden access to safer blood products.

    More Related Videos

    Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination10:32

    Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

    Published on: August 24, 2015

    Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol09:12

    Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol

    Published on: April 5, 2024

    Related Concept Videos

    Blood Transfusion and Agglutination02:45

    Blood Transfusion and Agglutination

    Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
    History
    The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...